Skip to main content

Table 1 Patient information for the training and validation sets

From: Prediction of subsolid pulmonary nodule growth rate using radiomics

Characteristic

 

Training cohort

Validation cohort

P value

Participants

 

600

257

 

Age(year)

 

62.91 ± 14.11

63.93 ± 14.05

0.332

Gender

   

0.397

 

Male

275(45.83%)

120(46.70%)

0.817

 

Female

325(54.17%)

137(53.31%)

 

Density

   

0.995

 

GGN

238(39.67%)

102(39.69%)

 
 

PSN

362(60.33%)

155(60.31%)

 

Shape

   

0.912

 

Round

157(26.17%)

70(27.24%)

 
 

Oval

51(8.5%)

23(8.95%)

 
 

Irregular

392(65.33%)

164(63.81%)

 

Location

   

0.862

 

RU

223(37.17%)

96(37.35%)

 
 

RM

61(10.17%)

24(9.34%)

 
 

RL

94(15.67%)

34(13.23%)

 
 

LU

150(25.00%)

70(27.24%)

 
 

LL

72(12.00%)

33(12.84%)

 

Lobulation

Present

446(74.33%)

188(73.15%)

0.718

 

Absent

154(25.67%)

69(26.84%)

 

Spiculation

Present

328(54.67%)

142(55.25%)

0.874

 

Absent

272(45.33%)

115(44.75%)

 

Bubble

Present

60(10.00%)

35(13.62%)

0.218

 

Absent

540(90.00%)

222(86.38%)

 

Bronchiole change

Present

211(35.17%)

98(38.13%)

0.407

 

Absent

389(64.83%)

159(61.87%)

 

Vascular change

Present

129(21.50%)

51(19.84%)

0.586

 

Absent

471(78.50%)

206(80.16%)

 

Pleural attachment

Present

187(31.17%)

85(33.07%)

0.583

 

Absent

413(68.83%)

172(66.93%)

 

History of lung cancer

Present

226(37.67%)

101(39.30%)

0.652

 

Absent

374(62.33%)

156(60.70%)

 

Growth rate

Fast-growth nodules

71(11.83%)

37(14.40%)

0.3

 

Slow-growth nodules

529(88.17%)

220(85.60%)

 
  1. Age is represented as the mean ± standard deviation; other data are represented as the number of patients with the percentage in parentheses
  2. PSN part-solid nodule, GGN ground-glass nodule, RU right upper, RM right middle, RL right lower, LU left upper, LL left lower